NAD+ and Muscle Loss: Too Much May Stall Muscle Repair Cells
Graded Preliminary — a review of nearly 60 selected animal and human studies that puts forward a hypothesis and collects no new data of its own.
Cell, tissue or computational study. Not evidence about people yet, which is why the grade is capped at Preliminary.
- Design
- Narrative review
- Participants
- N/A
- Duration
- —
- Funding
- —
A moderate NAD+ top-up may support muscle stem cells, while too much may hold them back, according to this hypothesis.
Muscles shrink and weaken with age, a condition called sarcopenia. A new review focuses on the muscle's own repair crew, its stem cells. The authors propose that NAD+, a molecule cells need to make energy, acts on these cells in two opposite ways.
The team pulled together nearly 60 selected studies in mice, rats and people. Data from monkeys were limited. In lab work, a moderate top-up of NAD+ supported the muscle stem cells. Precursors such as NMN or nicotinamide riboside raised NAD+ and switched on enzymes that boost the cell's power plants. Too much or poorly regulated NAD+, however, may trigger a different enzyme. That enzyme halts the stem cells from dividing and can wear them out over time.
This picture is not proven in people. The authors say direct evidence that low NAD+ drives muscle loss in humans is still limited. Most studies lasted only 4 to 12 weeks, were small, or tracked metabolic markers rather than muscle size and strength. There is no agreement yet on the right amount, timing or length of use.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
